{"altmetric_id":1551838,"counts":{"readers":{"mendeley":21,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["180239388660393"],"posts_count":1},"news":{"unique_users_count":2,"unique_users":["medicalxpress","science_daily"],"posts_count":2},"total":{"posts_count":9},"twitter":{"unique_users_count":6,"unique_users":["iApothecary","SympoRheumatolo","SympoPediatrics","SympoPharmaco","SympJIArthritis","SymRhmArthritis"],"posts_count":6}},"selected_quotes":["Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis."],"citation":{"abstract":"To determine the long-term safety and efficacy of rilonacept, an anti-interleukin-1 fusion protein, in patients with active systemic juvenile idiopathic arthritis (JIA).","abstract_source":"pubmed","altmetric_jid":"4f6fa4e83cf058f61000231f","authors":["Lovell DJ","Giannini EH","Reiff AO","Kimura Y","Li S","Hashkes PJ","Wallace CA","Onel KB","Foell D","Wu R","Biedermann S","Hamilton JD","Radin AR","Lovell, Daniel J.","Giannini, Edward H.","Reiff, Andreas O.","Kimura, Yukiko","Li, Suzanne","Hashkes, Philip J.","Wallace, Carol A.","Onel, Karen B.","Foell, Dirk","Wu, Richard","Biedermann, Stephanie","Hamilton, Jennifer D.","Radin, Allen R."],"doi":"10.1002\/art.38042","endpage":"2496","first_seen_on":"2013-06-12T18:52:31+00:00","isbns":[],"issns":["1529-0131","0004-3591","00043591"],"issue":"9","journal":"Arthritis & Rheumatism","last_mentioned_on":1381096586,"links":["http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.38042\/abstract","http:\/\/dx.doi.org\/10.1002\/art.38042","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23754188?dopt=Abstract","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23754188","http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.38042\/abstract?systemMessage=Wiley+Online+Library+will+be+disrupted+on+31+August+from+10%3A00-12%3A00+BST+%2805%3A00-07%3A00+EDT%29+for+essential+maintenance"],"pdf_url":"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.38042\/pdf","pmid":"23754188","pubdate":"2013-01-01T00:00:00+00:00","scopus_subjects":["Health Sciences","Medicine","Life Sciences","Immunology and Microbiology"],"startpage":"2486","subjects":["rheumatology"],"title":"Long-Term Safety and Efficacy of Rilonacept in Patients with Systemic Juvenile Idiopathic Arthritis (sJIA).","type":"article","volume":"65","mendeley_url":"http:\/\/www.mendeley.com\/research\/longterm-safety-efficacy-rilonacept-patients-systemic-juvenile-idiopathic-arthritis"},"altmetric_score":{"score":20.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":20.25},"context_for_score":{"all":{"total_number_of_other_articles":8008728,"mean":6.7638635453503,"rank":396508,"this_scored_higher_than_pct":95,"this_scored_higher_than":7612138,"rank_type":"exact","sample_size":8008728,"percentile":95},"similar_age_3m":{"total_number_of_other_articles":123616,"mean":6.8795668972213,"rank":7202,"this_scored_higher_than_pct":94,"this_scored_higher_than":116399,"rank_type":"exact","sample_size":123616,"percentile":94},"this_journal":{"total_number_of_other_articles":2216,"mean":4.6395124153499,"rank":71,"this_scored_higher_than_pct":96,"this_scored_higher_than":2145,"rank_type":"exact","sample_size":2216,"percentile":96},"similar_age_this_journal_3m":{"total_number_of_other_articles":20,"mean":4.9131578947368,"rank":2,"this_scored_higher_than_pct":90,"this_scored_higher_than":18,"rank_type":"exact","sample_size":20,"percentile":90}}},"demographics":{"poster_types":{"member_of_the_public":5,"researcher":1},"users":{"twitter":{"cohorts":{"Scientists":1,"Members of the public":5}},"mendeley":{"by_status":{"Professor > Associate Professor":3,"Librarian":1,"Researcher":5,"Student  > Doctoral Student":4,"Student  > Ph. D. Student":2,"Other":2,"Student  > Master":2,"Professor":1,"Student  > Bachelor":1},"by_discipline":{"Medicine and Dentistry":11,"Neuroscience":1,"Psychology":3,"Agricultural and Biological Sciences":5,"Unspecified":1}}},"geo":{"twitter":{"US":1},"mendeley":{"US":1,"GB":1}}},"posts":{"facebook":[{"title":"Long-term safety and efficacy of rilonacept ... [Arthritis Rheum. 2013] - PubMed - NCBI","url":"https:\/\/www.facebook.com\/180239388660393\/posts\/673864772631183","license":"public","citation_ids":[1551838],"posted_on":"2013-10-06T21:56:26+00:00","summary":"La seguridad a largo plazo y la eficacia de rilonacept en pacientes con artritis idiop\u00e1tica juvenil sist\u00e9mica\nhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23754188?dopt=Abstract\nhttp:\/\/translate.google.com.ar\/translate?sl=en&tl=es&js=n&prev=_t&hl=es&ie=UTF-8&u=http%","author":{"name":"Universo de enfermedades","url":"https:\/\/www.facebook.com\/180239388660393","facebook_wall_name":"Universo de enfermedades","image":"https:\/\/graph.facebook.com\/180239388660393\/picture","id_on_source":"180239388660393"}}],"twitter":[{"url":"http:\/\/twitter.com\/iApothecary\/statuses\/372655883412451328","license":"public","citation_ids":[1551838],"posted_on":"2013-08-28T09:44:20+00:00","author":{"name":"Ed","url":"https:\/\/medquestreviews.com","image":"https:\/\/pbs.twimg.com\/profile_images\/876661938226315264\/o3XVOtB6_normal.jpg","description":"Board certified infectious diseases specialist & HIV researcher. Adjunct professor & author of pharmacology for USMLE. Jazz aficionado & LGBT+ affairs advocate.","id_on_source":"iApothecary","tweeter_id":"445879553","geo":{"lt":40.78343,"ln":-73.96625,"country":"US"},"followers":1499},"tweet_id":"372655883412451328"},{"url":"http:\/\/twitter.com\/SympoRheumatolo\/statuses\/344889910190288896","license":"datasift","citation_ids":[1551838],"posted_on":"2013-06-12T18:52:16+00:00","author":{"name":"Symposier Rheumato","url":"http:\/\/www.symposier.com","image":"https:\/\/pbs.twimg.com\/profile_images\/732267724\/SympoLogo_normal.jpg","description":"Symposier integrated tweets about Rheumatology. Learn more about the chronic condition affecting you, your loved one or patient.","id_on_source":"SympoRheumatolo","tweeter_id":"87727820","geo":{"lt":null,"ln":null},"followers":953},"tweet_id":"344889910190288896"},{"url":"http:\/\/twitter.com\/SympoPediatrics\/statuses\/344889915697410048","license":"datasift","citation_ids":[1551838],"posted_on":"2013-06-12T18:52:18+00:00","author":{"name":"Symposier Pediatrics","url":"http:\/\/t.co\/Nyu9vr4dwk","image":"http:\/\/a0.twimg.com\/profile_images\/698525792\/SympoLogo_normal.jpg","description":"Symposier integrated tweets about Pediatrics. Learn more about the chronic condition affecting you, your loved one or patient.","id_on_source":"SympoPediatrics","tweeter_id":"86609599","followers":1506},"tweet_id":"344889915697410048"},{"url":"http:\/\/twitter.com\/SympoPharmaco\/statuses\/344889913931608064","license":"datasift","citation_ids":[1551838],"posted_on":"2013-06-12T18:52:17+00:00","author":{"name":"Symposier Pharmaco","url":"http:\/\/t.co\/J94o40xNrR","image":"http:\/\/a0.twimg.com\/profile_images\/675964347\/SympoLogo_normal.jpg","description":"Symposier integrated tweets about Pharmacology and Pharmaceutic Industry. Learn more about the chronic condition affecting you, your loved one or patient.","id_on_source":"SympoPharmaco","tweeter_id":"87869965","followers":750},"tweet_id":"344889913931608064"},{"url":"http:\/\/twitter.com\/SympJIArthritis\/statuses\/344889917811335168","license":"datasift","citation_ids":[1551838],"posted_on":"2013-06-12T18:52:18+00:00","author":{"name":"Sympo JI Arthritis","url":"http:\/\/t.co\/ZQUNi7GRIL","image":"http:\/\/a0.twimg.com\/profile_images\/3280991404\/20a2295d9c9fa4754ba5030b97c2bf09_normal.jpeg","description":"Symposier integrated tweets about Juvenile idiopathic arthritis. Learn more about the chronic condition affecting you, your loved one or patient.","id_on_source":"SympJIArthritis","tweeter_id":"1199538169","followers":90},"tweet_id":"344889917811335168"},{"url":"http:\/\/twitter.com\/SymRhmArthritis\/statuses\/344889912186773505","license":"datasift","citation_ids":[1551838],"posted_on":"2013-06-12T18:52:17+00:00","author":{"name":"Sympo Rhma Arthritis","url":"http:\/\/t.co\/xUpK2DTdja","image":"http:\/\/a0.twimg.com\/profile_images\/3284620844\/20a2295d9c9fa4754ba5030b97c2bf09_normal.jpeg","description":"Symposier integrated tweets about Rheumatoid arthritis. Learn more about the chronic condition affecting you, your loved one or patient.","id_on_source":"SymRhmArthritis","tweeter_id":"1202371646","followers":113},"tweet_id":"344889912186773505"}],"news":[{"title":"Recommendations guide physicians in treatment of systemic juvenile arthritis","url":"http:\/\/medicalxpress.com\/news\/2013-09-physicians-treatment-juvenile-arthritis.html","license":"public","citation_ids":[1780901,1779147,1780901,1551838,1551838,1779147],"posted_on":"2013-09-24T05:00:02+00:00","summary":"In the U.S., there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses according to estimates from the American College of Rheumatology (ACR). For pediatric patients with systemic juvenile idiopathic arthritis (JIA), effective","author":{"name":"MedicalXpress","url":"http:\/\/medicalxpress.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/152\/normal\/image.png?1369925783"}},{"title":"Recommendations guide physicians in treatment of systemic juvenile arthritis","url":"http:\/\/www.sciencedaily.com\/releases\/2013\/09\/130924091806.htm?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+sciencedaily+%28ScienceDaily%3A+Latest+Science+News%29","license":"public","citation_ids":[1780901,1780901,1551838,1779147],"posted_on":"2013-09-24T13:18:18+00:00","summary":"In the US, there are nearly 300,000 children with juvenile arthritis and other rheumatic illnesses. For pediatric patients with systemic juvenile idiopathic arthritis (JIA), effective treatment for this disabling disease is imperative. New treatment recomm","author":{"name":"Science Daily","url":"http:\/\/www.sciencedaily.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/179\/normal\/image.png?1369927053"}}]}}